Ryman Healthcare Limited Stock Probability Of Bankruptcy
Ryman Healthcare's odds of distress is below 50% at the present time. It has small probability of experiencing financial crunch in the next few years. Ryman Healthcare's Chance of financial distress is determined by interpolating and adjusting Ryman Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the Ryman balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
Ryman |
Ryman Healthcare Limited Company chance of financial distress Analysis
Ryman Healthcare's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Ryman Healthcare Probability Of Bankruptcy | Less than 44% |
Most of Ryman Healthcare's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ryman Healthcare Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Ryman Healthcare probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Ryman Healthcare odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Ryman Healthcare Limited financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, Ryman Healthcare Limited has a Probability Of Bankruptcy of 44.0%. This indicator is about the same for the Healthcare average (which is currently at 43.29) sector and significantly higher than that of the Medical Care Facilities industry. The probability of bankruptcy for all United States stocks is 10.47% lower than that of the firm.
Ryman Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ryman Healthcare's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ryman Healthcare could also be used in its relative valuation, which is a method of valuing Ryman Healthcare by comparing valuation metrics of similar companies.Ryman Healthcare is currently under evaluation in probability of bankruptcy category among its peers.
Ryman Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 | |||
| Profit Margin | 1.13 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 4.01 B | |||
| Shares Outstanding | 500 M | |||
| Shares Owned By Insiders | 17.22 % | |||
| Shares Owned By Institutions | 26.40 % | |||
| Price To Earning | 11.98 X | |||
| Price To Book | 1.08 X | |||
| Price To Sales | 4.64 X | |||
| Revenue | 503.76 M | |||
| Gross Profit | 42.52 M | |||
| EBITDA | 788.44 M | |||
| Net Income | 692.87 M | |||
| Cash And Equivalents | 47.88 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 2.58 B | |||
| Debt To Equity | 0.76 % | |||
| Current Ratio | 0.71 X | |||
| Book Value Per Share | 7.26 X | |||
| Cash Flow From Operations | 585.98 M | |||
| Earnings Per Share | 0.77 X | |||
| Price To Earnings To Growth | 2.97 X | |||
| Number Of Employees | 6.8 K | |||
| Beta | 0.79 | |||
| Market Capitalization | 2.08 B | |||
| Total Asset | 10.97 B | |||
| Retained Earnings | 1.28 B | |||
| Working Capital | 114 M | |||
| Current Asset | 221 M | |||
| Current Liabilities | 107 M | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 10.97 B | |||
| Last Dividend Paid | 0.22 |
About Ryman Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ryman Healthcare Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ryman Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ryman Healthcare Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Ryman Pink Sheet
Ryman Healthcare financial ratios help investors to determine whether Ryman Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.